Skip to main content
search
Category

Consultations

ConsultationsConsultations ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

Machinery safety legislation: call for evidence

Machinery safety legislation: call for evidence Page summary: We are inviting views on the introduction across the UK of measures in the EU Machinery Regulation 2023/1230. Change made: Call for evidence response published. Time updated: 10:01am, 25 February 2026
Ben Kemp
March 5, 2026
ConsultationsConsultations Archive

Consultation: Health Service Products (Provision and Disclosure of Information) Regulations 2018

The Department of Health and Social Care (DHSC) proposes to amend the Health Service Products (Provision and Disclosure of Information) Regulations 2018 (the information regulations). This consultation document seeks views on the proposals, particularly from stakeholders involved in the pharmaceutical supply chain. The information regulations require persons who manufacture, distribute or supply any UK health service products to record, keep and…
Ben Kemp
March 3, 2026
ConsultationsConsultations ArchiveMembership NewsMembership News Archive

New NICE consulation: Statement of intent on NICE’s approach to ongoing evaluations ahead of proposed changes to NICE’s standard cost-effectiveness thresholds

Following the closure of NICE's consultation of ministerial intervention into their cost-effectiveness thresholds, the organisation has released a further consultation on their statement of intent to ongoing evaluations. For reference, NICE uses cost-effectiveness thresholds in health economic evaluations to determine whether health technologies represent value for money for use in the NHS in England. Subject to parliamentary approval, DHSC processes…
Ben Kemp
January 21, 2026
ConsultationsConsultations ArchiveMembership NewsMembership News ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

MHRA: National AI Commission Call for Evidence

The MHRA have released a Call for Evidence regarding the regulation of AI in healthcare. This evidence will then inform the recommendations of the National Commission into the Regulation of AI in Healthcare. The Commission is a body which brings together experts from technology, healthcare, law, patient groups, the public, government, and the NHS. The MHRA is particularly keen to…
Ben Kemp
January 6, 2026
ConsultationsConsultations ArchiveMembership NewsMembership News Archive

Changes to NICE regulations: cost-effectiveness threshold – members’ views needed

The UK government has proposed assuming direct control over the cost-effectiveness thresholds used by the National Institute for Health and Care Excellence (NICE), the body responsible for assessing the value of medicines and medical technologies. The proposal applies to both pharmaceuticals and medical devices. Under the proposal, responsibility for setting the threshold would move from NICE’s independent board to government…
Ben Kemp
January 5, 2026
ConsultationsConsultations ArchiveMembership NewsMembership News ArchiveRegulatory Affairs NewsletterRegulatory Affairs Newsletter ArchiveUK Government Updates Regulatory Affairs NewsletterUK Government Updates Regulatory Affairs Newsletter Archive

AI Growth Lab: Call for Evidence

The MHRA are seeking evidence on a pioneering cross-economy sandbox, that would oversee the deployment of AI-enabled products and services that current regulation hinders. The Lab would deliver more dynamic UK regulation. Regulatory decisions on novel technologies can often take years, but we know that regulatory sandboxes can accelerate time to market by 40%. The AI Growth Lab would support…
Ben Kemp
October 28, 2025
ConsultationsConsultations ArchiveMembership NewsMembership News Archive

NICE: New kidney cancer guidelines, including consultation

NICE has published new guidance on kidney cancer which says that more people should have a biopsy to confirm their diagnosis sooner. The new draft guidelines could see the number of biopsies increase to around 1,200 procedures a year. The NICE guideline: Recommends offering a biopsy to help confirm the diagnosis and inform treatment options for people with suspected renal…
Ben Kemp
September 22, 2025
ConsultationsConsultations ArchiveMembership NewsMembership News Archive

DHSC Call for Evidence on Pathology Managed Services – deadline extended to 19th September

The Department of Health and Social Care (DHSC) has extended the deadline for its Call for Evidence on Pathology Managed Service Contracts to 19th September 2025, allowing members more time to take advantage of this vital opportunity for our industry to shape the future of pathology procurement in the NHS. Managed service contracts are central to how pathology services operate. The decisions…
Ben Kemp
September 1, 2025
ConsultationsConsultations ArchiveMembership NewsMembership News Archive

Reminder: Pathology Managed Service Contracts Call for Evidence closes 5th September

A reminder to all members that the Pathology Managed Service Contracts Call for Evidence closes 5th September. BIVDA has pressed government on this issue for a long time. This, therefore, provides a crucial opportunity to help DHSC with the development of policy guidance in this area. We are encouraged by member engagement so far, following two webinars with Head of…
Ben Kemp
August 20, 2025
Close Menu